ArticleThe EMBO journal2023

CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS.

Jia Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.